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Abstract
Background: middle and late latency auditory evoked potentials. Aim: to verify the occurrence of middle
and late latency auditory evoked potentials disorders in adults with Acquired Immunodeficiency Syndrome
(AIDS). Method: middle and late latency auditory evoked potentials of 8 individuals with AIDS, with ages
ranging from 10 to 51 years, with normal hearing, or with sensoryneural hearing losses up to moderate,
and normal results in the Auditory Brainstem Response, comparing the results with the responses obtained
for a control group which was composed by 25 individuals, with ages ranging from 19 to 24 years, with
no hearing complaints and with normal hearing and normal results in the Auditory Brainstem Response.
Results: the Pa wave latency and amplitude averages in the C3/A2 and C4/A1 modalities, and the average
of the P300 wave were analyzed. No significant differences were observed in the Pa wave amplitude and
latency averages between the groups, although a non-statistically significant increase was observed in the
latency and a decrease in the amplitude of such wave for the research group in the C3/A2 modality. The
latency of the P300 wave was significantly longer to the left for the research group. It was also observed
a longer latency to the right, although this was not statistically significant. Conclusion: adult individuals
with AIDS do not present alterations in the middle latency auditory evoked potential and do present
alterations in the cognitive potential, indicating a disorder in the cortical regions of the auditory pathway
and a deficit in the cognitive processing of auditory information for this population. Such findings stress
the importance of a careful investigation of the auditory function of individuals with AIDS, thus favoring
the therapeutic planning.
Key Words: Auditory Evoked Potentials; P300 Event-Related Potentials; Acquired Immunodeficiency
Syndrome.
Resumo
Tema: potenciais evocados auditivos de média e longa latências. Objetivo: verificar a ocorrência de
alterações nos potenciais evocados auditivos de média e longa latências em indivíduos adultos portadores
da síndrome da imunodeficiência adquirida (AIDS). Método: foram obtidos os potenciais evocados auditivos
de média e longa latências em oito indivíduos com AIDS, de 10 a 51 anos de idade, que apresentavam
audição normal ou até perda auditiva neurossensorial de grau moderado e resultados normais na Audiometria
de Tronco Encefálico, comparando os resultados com os obtidos no grupo controle constituído por 25
indivíduos, de 19 a 24 anos de idade, sem queixas auditivas e com audição dentro da normalidade, bem
como com resultados normais na Audiometria de Tronco Encefálico. Resultados: foram analisadas as
médias das latências e amplitudes da onda Pa, nas modalidades contralaterais C3/A2 e C4/A1, e da latência
da onda P300. Não foram observadas diferenças estatisticamente significantes com relação às médias da
amplitude e latência da onda Pa entre os grupos, embora tenha sido observado um aumento da latência e
diminuição da amplitude de tal onda, ainda que não estatisticamente significante, para o grupo estudo na
modalidade C3/A2. A latência da onda P300 mostrou-se significantemente aumentada para o lado esquerdo
no grupo estudo, sendo também possível observar um aumento da latência, embora não estatisticamente
significante, para o lado direito. Conclusão: indivíduos adultos com AIDS não apresentam alterações no
potencial evocado auditivo de média latência e apresentam alterações no potencial cognitivo sugerindo,
desta forma, comprometimento da via auditiva em regiões corticais e déficit no processamento cognitivo
das informações auditivas nesta população. Tais achados reforçam a importância de uma investigação
minuciosa da função auditiva em indivíduos com AIDS auxiliando, desta forma, no delineamento da
conduta terapêutica junto a estes pacientes.
Palavras-Chave: Potenciais Evocados Auditivos; Potencial Evocado P300; Síndrome da Imunodeficiência
Adquirida.
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Introduction
In the Acquired Immunodeficiency Syndrome
(AIDS) caused by the human immunodeficiency
virus (HIV), a progressive compromise of the
immune response of the individual occurs making
him/her susceptible to a number of opportunistic
infections. With the development of the disease, a
progressive impairment of the central nervous
system (CNS) may occur including the central
auditory system, either due to the direct action of
the virus on the CNS affecting the maturational
process, or due to opportunistic infections (Chow
et al., 2005).
From the clinical point of view, the infection
caused by the HIV and AIDS are distinct entities.
Many individuals infected by the HIV also present
a normal amount of immunologic cells, remaining
asymptomatic for long periods of time. Despite
being affected by the HIV, those individuals don't
match the clinical definition of AIDS.
In order to be clinically defined as having AIDS
the HIV-positive individuals must present low
amount of immunologic cells (CD4 < 350) or develop
at least one clinical condition that defines AIDS.
According to the American National Health
Institute about 75% of adults with AIDS present
some kind of auditory dysfunction due to
opportunistic infections or to ototoxic effect
treatments.
The incidence of hearing disorders in patients
with HIV/AIDS varies approximately from 20 to 40%
(Chandrasekhar et al., 2000; Mata Castro et al., 2000;
Khoza & Ross, 2002), and the hearing loss may be
due to external, middle or inner ear disorders.
Within the innumerous infections that
individuals with AIDS might have, there are the
otitis that may cause a temporary peripheral hearing
loss and should be identified as early as possible
in order for the adequate medical treatment to be
established.
Individuals with HIV/AIDS may also present
an inner ear impairment due to the direct action of
the virus (Chandrasekhar et al., 2000; Mata Castro
et al., 2000; Khoza & Ross, 2002), as well as to the
use of anti-retroviral drugs or ototoxic medicine
(Sindom et al., 2000; Williams, 2001; Rey et al., 2002),
causing a sensorineural hearing loss.
Due to these impairments we may find
abnormalities in the tests that evaluate the central
auditory processing reflecting difficulties in the
attention, discrimination, recognition and
comprehension of auditory information (Roland Jr.
et al., 2003).
Besides the behavioral hearing tests failures,
there are abnormalities in middle and late auditory
evoked potentials following the progress of the
disease.
Nowadays, the auditory evoked potentials are
of great use in the audiological practice; when
associated to the behavioral hearing evaluation they
make the diagnosis of central or cognitive auditory
disorders more precise (Junqueira & Frizzo, 2002).
The fact that they are obtained objectively
and non-invasively allows the use of such
potentials to evaluate auditory processing disorders
(APD). Such responses don't depend on the
subject's linguistic skills and, except from the late
potentials, they don't demand a cognitive
processing of the sound stimulus (Schochat, 2003).
The middle latency auditory response (MLR) is
a synchronic auditory evoked potential that occurs
in a time space of approximately 100 milliseconds
(ms) after the auditory stimulation composed by a
series of positive and negative waves. The first
MLR wave is the Na (occurring at around 18 ms)
followed by the Pa (30 ms), Nb (40 ms), Pb (50 ms)
and sometimes, Nc and Pc; the Pa wave has the
greatest amplitude, and is more consistent and more
frequently used (Musiek & Lee, 2001).
The MLR has multiple generators reflecting
primary and non-primary areas, such as the reticular
formation, the thalamus divisions; with a greater
contribution of the thalamo-cortical pathways and
with a lesser contribution of the inferior colliculi
(mesencephalus) and auditory cortex (Budinger &
Scheich, 2000).
The late latency potentials are less affected by
the physical properties of the stimulus and are more
affected by the functional use that the individual
makes of the stimulus, being less determined by
the frequency or intensity, and more by the
attention to the sound stimulus. Such potentials
are originated in the primary and secondary areas
of the auditory cortex being useful in the cognitive
and attention functions study.
The P300, also called cognitive potential, is a
positive late latency auditory evoked potential
generated by a series of stimuli (frequent) and by
the occasional occurrence of a less frequent
stimulus (rare) that appears randomly. The rare
stimulus occurs from 15 to 20% of the total stimuli,
and the subject should identify it counting mentally
or pressing a button every time it occurs. At each
screening, two waves are recorded; one for the
frequent stimulus and one for the rare stimulus.
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The auditory system habituates to hearing the
frequent stimulus and, therefore less neurons
answer to this stimulus. Concerning the rare
stimulus, as it is heard less times, the system
answers to this stimulus with more neurons
generating a wave with greater amplitude. The P300
is obtained subtracting the rare stimulus from the
frequent one (Schochat, 2003).
The P300 wave is the greatest positive wave
after the complex N1-P2 occurring between 240 and
700 ms (Junqueira & Colafêmina, 2002).
A latency increase or an amplitude decrease
indicate clinical and sub-clinical problems.
According to Picton (1992) if the P300 is small or
late, there will probably be a deficit in the cognitive
processing. The latency is a more reliable indicator
than the amplitude, once the amplitude is difficult
to be altered as a function of the attention.
It is known that individuals with AIDS may
present a progressive compromise of the central
nervous system, including the central auditory
system, by the direct action of the virus on the
system's structures leading to the presence of
electrophysiological abnormalities in the brainstem
auditory evoked potentials, middle and late
latencies evoked potentials, including the P300
(Reyes et al., 2002). According to Bankaitis et
al.(1998), these abnormalities go along with the
disease progression.
The findings of Matas et al. (2000) and Matas
et al. (2002) reported a greater incidence of hearing
disorders suggestive of central auditory impairment
in HIV positive children.
Several studies have documented disorders in
the auditory evoked potentials of patients with
AIDS (Martin et al., 2001; Polich & Basho, 2002;
Chao et al., 2004; Tartar et al., 2004).
As AIDS has been spreading in the past few
years and the otorhinolaryngologic manifestations
have been more documented, several studies in the
literature emphasize the importance of the
audiological evaluation of these patients, not only
for a more effective diagnosis, but also aiming at a
rehabilitation process.
The present study aimed to verify the
occurrence of middle and late latency auditory
evoked potentials disorders in adult individuals with
the acquired immunodeficiency syndrome (AIDS).
Method
The study had its start after the approval of the
Ethics Committee for Research Projects Analysis -
CAPPesq from the Clinical Board of the Hospital das
Clínicas and from the Medical School of University
of São Paulo (FMUSP), protocol number 1026/04.
The participants signed the Informed Consent Term
in which all procedures were described.
All individuals were referred by the Audiology
Service to the Speech and Hearing Laboratory in
Auditory Evoked Potentials of the FMUSP. The
audiological evaluation as well as the brainstem
auditory evoked potentials were previously carried
out.
Thirty three subjects from 10 to 51 years of age
took part in the study. In the control group, 25 normal
individuals were evaluated, being 5 male and 20
female ranging in age from 19 to 24 years.
The study group was composed by 8 subjects
with AIDS, 4 male and 4 female, presenting normal
hearing or even a moderate sensorineural hearing
loss including the frequencies from 3 to 6 kHz, and
normal brainstem auditory evoked potentials results.
Initially, the individuals underwent an anamnesis
gathering information related to the virus infection,
to the presence of risk factors for hearing loss, to
otitis complaints, among other disorders related to
the external and middle ears.
Next, the inspection of the external acoustic
meatus was performed using an otoscope to verify
the conditions for the electrophysiological
examination.
The electrophysiological evaluation was done
with the portable system Bio-Logic Traveler Express.
In order to get the middle latency auditory evoked
potential (MLR), the subject's skin was cleaned with
an abrasive paste and the electrodes were placed
through an electrolytic paste and a seller tape
(micropore) on pre-determined positions: A1, A2, C3,
C4 and Cz, according to the IES 10-20 (International
Electrode System).
The impedance values of the electrodes were
verified and they should be below 5 kOhms. The
acoustic stimulus was presented through a pair of
earphones eliciting the responses.
The stimulus used was the click presented
monaurally at 70 dB HL in a presentation rate of 10
clicks per second, totalizing 1000 clicks.
The MLR results were analyzed concerning the
Pa wave latency and amplitude obtained in the
contralateral modalities (C3/A2 and C4/A1), once
according to the specialized literature the
contralateral modality is the most indicated one to
analyze the variables that will be studied (Hall, 1992).
In order to obtain the P300, the electrodes were
placed on the skin in the positions A1, A2, Cz and
Fz also according to the IES 10-20 (International
Electrode System).
The tone burst sound stimuli were presented at
75 dB HL. The rare stimulus (1500Hz) occurred from
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15 to 20% of the total of 300 stimuli and was
presented randomly by the computer.
Results
The average and the standard deviation of the
Pa wave latency were calculated for the contralateral
modalities (C3/A2 and C4/A1) in the control and
study groups.
Then, the averages of the Pa wave latencies
were compared between the control and the study
group using the Student's t-test adjusted by the
Levene's test for equality of variance, with a
significance level of 0,05 (5%) (Table 1).
No significant statistical differences were found
regarding the averages of the Pa wave latency
between the control and the study groups, either
for the modality C3/A2 as for the C4/A1.
The average and standard deviation of the Pa
wave amplitudes were also calculated for the
contralateral modalities (C3/A2 and C4/A1) in the
control and the study groups.
Then, the averages of the Pa wave amplitudes
were compared between the control and the study
group using the Student's t-test adjusted by the
Levene's test for equality of variance, with a
significance level of 0,05 (5%) (Table 2).
No significant statistical differences were found
regarding the averages of the Pa wave amplitude
between the control and the study groups, either
for the modality C3/A2 as for the C4/A1.
For the P300 analysis, the average and the
standard deviation of this wave latency, whenever
present in the right and left ears, were calculated.
The averages of the P300 wave latency were
compared between the control and the study group
using the Student's t-test adjusted by the Levene's
test for equality of variance, with a significance
level of 0,05 (5%) (Table 3).
Significant statistical differences were found
regarding the P300 wave latency between the
control and the study groups for the left side.
.
Discussion
Several studies in the literature emphasize the
importance of the auditory evoked potentials for
population at risk for central auditory disorders
including individuals with AIDS. According to
Picton (1992), latency increases or amplitude
decreases of auditory evoked potentials are
evidences of clinical and sub-clinical problems.
In the middle latency auditory evoked potential
(MLR), the averages of the Pa wave latencies for
the contralateral modalities C3/A2 and C4/A1, when
compared between the control and the study
groups, did not reveal significant statistical
differences. The Pa wave latency occurred around
32 ms either for the control group as for the study
group in the modality C4/A1. For the modality C3/
A2, while in the control group the Pa wave latency
was at 31 ms, in the study group it was possible to
observe a slight increase of this wave latency when
compared to the control group, being present
Table 1 - Comparison of the averages and Standard deviation of the Pa wave
latency between the control and the study groups.
Table 2 - Comparison of the averages and Standard deviation of the Pa wave
amplitude between the control and the study groups.
Table 3 - Comparison of the averages and standard deviation of the P300
wave latency between the control and the study groups.
Variable GROUP n Average Standard deviation Significance (p) 
Study 8 32,74 4,90 PA_C4A1 Control 25 32,85 3,84 0,205 
Study 8 34,76 6,86 PA_C3A2 Control 25 31,00 4,14 0,272 
 
Variable GROUP n Average Standard deviation Significance (p) 
Study 8 0,83 0,54 Amplitude_C4/A1 Control 25 1,40 1,17 0,257 
Study 8 1,00 0,99 Amplitude_C3/A2 Control 25 1,42 1,61 0,885 
 
Variable GROUP n Average Standard deviation Significance (p) 
Study 8 355,25 52,86 P300_RE Control 25 309,88 27,30 0,109 
Study 7 368,00 52,40 P300_LE Control 25 308,84 20,82 < 0,001 
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around 34 ms. This finding agrees with the study
of Schmitt et al. (1992), who reported an increase of
the Pa wave of subjects with AIDS.
The comparison of the Pa wave amplitudes in
the contralateral modalities (C3/A2 and C4/A1)
revealed no significant statistical difference
between the groups. In the control group, the Pa
wave presented mean amplitude of 1,4  V in the
modalities C3/A2 and C4/A1. It was possible to
observe a tendency in the study group, although
not statistically significant, to decrease the Pa wave
amplitude, once this amplitude was 0,8  V in the
modality C4/A1 and 1,0  V in the modality C3/A2.
The results obtained in this research through
the statistical analysis performed, despite not being
the most frequently observed in the specialized
literature that reports an increase of the MLR waves
latencies in individuals with AIDS (Bankaitis et al.,
1998), could be justified by the small sample (N=8)
and also by the great variability of the MLR waves
latencies inter-subject.
Such fact demonstrates that further researches
should be carried out in this field.
In the late latency auditory evoked potential,
the averages of the P300 wave latencies in the right
ear did not show significant statistical difference
when compared between the groups; this finding
could also be justified by the great variability of
the mean time of the P300 wave intra-subject.
Despite not being statistically significant, it was
possible to observe a slight increase of this wave
latency when compared to the control group, being
present at around 355 ms in the group of individuals
with AIDS, and around 309 ms in the control group
for the right ear.
The results analysis revealed a significant
statistical difference in the P300 wave latencies for
the left ear. In the control group, this wave appeared
around 308 ms, while in the study group it was
found at around 368 ms.
According to Picton (1992), the P300 latency is
a more reliable indicator than the P300 amplitude,
since this last one is difficult to be altered as a
function of the attention; this is the reason why
only the P300 wave latency was studied in this
research.
Several authors also reported alterations in the
P300 in individuals with HIV/AIDS.
In Tartar et al. (2004) study with symptomatic
and asymptomatic HIV positive individuals and
HIV negative individuals, alterations of the P300
wave were described in both groups with HIV, being
more evident in the symptomatic individuals, that
is the individuals with AIDS, following their
cognitive decline. The authors concluded that the
P300 is a complementary exam that is useful to mark
the cognitive decline in the diagnostic and
treatment of AIDS.
Significant differences in the P300 latency in
HIV positive patients were also reported by Fein et
al. (1996) and Polich et al. (2000). In the first study,
it was observed a 12 ms delay of the P300
component in subjects with AIDS and the delay
magnitude was directly related to the severity of
the cognitive compromise of such subjects. For the
authors, the P300 latency delay is associated to the
disease progression once the cognitive capacity
decline is considered one of the symptoms that
could be present in patients with AIDS, being
directly proportional to the individual viral rate.
Corroborating the findings of this research,
Reyes et al. (2002) also found significant statistical
differences in the auditory evoked potentials of
individuals with AIDS, therefore being possible to
assume that HIV may compromise the auditory
nervous system, which could be detected through
auditory evoked potentials.
Conclusion
From the data obtained in this study it is possible
to conclude that adult individuals with AIDS don't
present middle latency auditory evoked potential
alteration and do present cognitive potential
alteration, suggesting thus a compromise in the
cortical regions of the auditory pathway and a deficit
in the cognitive processing of auditory information
in this population.
Such findings emphasize the importance of a
detailed investigation of the auditory function of
individuals with AIDS aiming at the identification of
possible alterations that could be associated with
this pathology, as well as the characterization of the
type of damage and its possible causes
(compromising the peripheral auditory system -
external, middle or inner ears, and/or central auditory
system) helping thus, the establishment of the
therapeutic follow up with these patients.
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